Cargando...
Modified metformin as a more potent anticancer drug: Mitochondrial inhibition, redox signaling, antiproliferative effects and future EPR studies
Metformin, one of the most widely prescribed antidiabetic drugs in the world is being repurposed as a potential drug in cancer treatment. Epidemiological studies suggest that metformin exerts anticancer effects in diabetic patients with pancreatic cancer. However, at typical antidiabetic doses the b...
Guardado en:
| Publicado en: | Cell Biochem Biophys |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5680142/ https://ncbi.nlm.nih.gov/pubmed/28429253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12013-017-0796-3 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|